SK287324B6 - Trojsodná soľ kyseliny 4-amino-1-hydroxybutylidén-1,1- bisfosfónovej - Google Patents
Trojsodná soľ kyseliny 4-amino-1-hydroxybutylidén-1,1- bisfosfónovej Download PDFInfo
- Publication number
- SK287324B6 SK287324B6 SK5103-2005A SK51032005A SK287324B6 SK 287324 B6 SK287324 B6 SK 287324B6 SK 51032005 A SK51032005 A SK 51032005A SK 287324 B6 SK287324 B6 SK 287324B6
- Authority
- SK
- Slovakia
- Prior art keywords
- trisodium
- alendronate
- water
- amino
- hydroxybutylidene
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CZ20041249A CZ297262B6 (cs) | 2004-12-28 | 2004-12-28 | Trisodná sul kyseliny 4-amino-1-hydroxybutyliden-1,1-bisfosfonové |
Publications (2)
Publication Number | Publication Date |
---|---|
SK51032005A3 SK51032005A3 (sk) | 2006-07-07 |
SK287324B6 true SK287324B6 (sk) | 2010-07-07 |
Family
ID=36658574
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK5103-2005A SK287324B6 (sk) | 2004-12-28 | 2005-12-15 | Trojsodná soľ kyseliny 4-amino-1-hydroxybutylidén-1,1- bisfosfónovej |
Country Status (2)
Country | Link |
---|---|
CZ (1) | CZ297262B6 (cs) |
SK (1) | SK287324B6 (cs) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT1107974E (pt) * | 1998-08-27 | 2006-10-31 | Teva Pharma | Novas formas de hidratos de alendronato de sodio, processos para a sua producao e suas composicoes farmaceuticas |
US6963008B2 (en) * | 1999-07-19 | 2005-11-08 | Teva Pharmaceutical Industries Ltd. | Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof |
GB2383042A (en) * | 2001-10-18 | 2003-06-18 | Cipla Ltd | Amorphous alendronate sodium |
ITMI20020146A1 (it) * | 2002-01-29 | 2003-07-29 | Lyogen Ltd | Alendronato monosodico amorfo e processo per la sua preparazione |
-
2004
- 2004-12-28 CZ CZ20041249A patent/CZ297262B6/cs not_active IP Right Cessation
-
2005
- 2005-12-15 SK SK5103-2005A patent/SK287324B6/sk not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
SK51032005A3 (sk) | 2006-07-07 |
CZ20041249A3 (cs) | 2006-08-16 |
CZ297262B6 (cs) | 2006-10-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10519176B2 (en) | Crystalline forms | |
CA2477350C (en) | Novel crystalline forms of the anti-cancer compound zd1839 | |
JP2009143955A (ja) | アレンドロネートナトリウムの新規水和物型、その製造方法、及びその医薬組成物 | |
EP3969449A1 (en) | New crystalline forms of n-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methvlphenyl)-2 (trifluoromethyl)isonicotinamide as raf inhibitors for the treatment of cancer | |
IL208152A (en) | Processes for the preparation of supernatant tosylate crystalline form iii, supernatant tosylate methanol solvate and supernatant tozylate ethanol solvate | |
EP1723157B1 (en) | Amorphous forms of risedronate monosodium | |
KR20120052381A (ko) | 프라수그렐 염의 결정형 | |
WO2007074475A2 (en) | Novel polymorphic forms of ibandronate | |
EP2710009B1 (en) | Novel crystalline asenapine hydrochloride salt forms | |
US20220002302A1 (en) | Novel polymorphs of acalabrutinib, a bruton's tyrosine kinase inhibitor | |
EP2710008A1 (en) | Novel crystalline salts of asenapine with organic di-acids and tri-acids | |
SK287324B6 (sk) | Trojsodná soľ kyseliny 4-amino-1-hydroxybutylidén-1,1- bisfosfónovej | |
EP2397458A1 (en) | Organic salts and co-crystals of phenylbutyric acid | |
SK50702005A3 (sk) | Trisodná soľ kyseliny 4-amino-1-hydroxybutylidén-1,1- bisfosfónovej | |
EP1928889A1 (en) | Pharmaceutically acceptable salts and hydrates of risedronic acid | |
EP3455229B1 (en) | Novel crystalline forms | |
EP3517529B1 (en) | Salt of quinazoline derivative, preparation method therefor and application thereof | |
US20060270633A1 (en) | Crystalline form of fosinopril calcium | |
JP2004091442A (ja) | 水溶性クエン酸マグネシウム含水塩およびその製法 | |
EP1702924A2 (en) | Novel hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereof | |
WO2013054146A1 (en) | New co crystals useful in the preparation of pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
TA4A | Addition of inventor(s) |
Effective date: 20101124 |
|
TC4A | Change of owner's name |
Owner name: ZENTIVA, K.S., PRAHA, DOLNI MECHOLUPY, CZ Effective date: 20120524 |
|
MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20121215 |